Sanofi (SNY) Asset Utilization Ratio (2018 - 2026)

Sanofi (SNY) posted Asset Utilization Ratio of 0.36 for Q2 2026, up 3.38% sequentially from 0.35 in Q1 2026, and up 19.33% YoY from 0.3 in Q2 2025.

Sanofi (SNY) Asset Utilization Ratio (2018 - 2026) Analysis & Trends

Sanofi has reported Asset Utilization Ratio for 3 years, with the latest figure at 0.36 in Q2 2026.

Quarterly Asset Utilization Ratio rose 19.33% year-over-year to 0.36 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.36 (up 19.33% YoY) and the FY2025 annual result came in at 0.35, up 11.36% from the prior year.
Asset Utilization Ratio advanced to 0.36 in Q2 2026 per SNY's latest filing, from 0.35 in the prior quarter.
Over five years, Asset Utilization Ratio peaked at 0.45 in Q3 2025 and troughed at 0.29 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Johnson & Johnson	652.77 Bn	632.01 Bn	17.26 Bn	0.49
2	AbbVie	469.90 Bn	463.33 Bn	12.70 Bn	0.47
3	Merck	377.04 Bn	369.90 Bn	12.21 Bn	0.52
4	Novartis Ag	303.08 Bn	295.39 Bn	11.24 Bn	-
5	Astrazeneca	257.74 Bn	252.84 Bn	12.86 Bn	0.53
6	Amgen	236.46 Bn	222.47 Bn	7.24 Bn	0.40
7	Gilead Sciences	181.81 Bn	178.63 Bn	6.22 Bn	0.58
8	Pfizer	159.20 Bn	147.50 Bn	10.94 Bn	0.31
9	Gsk	106.28 Bn	102.11 Bn	8.24 Bn	0.64
10	Sanofi	55.01 Bn	47.63 Bn	10.79 Bn	0.36

Download Data